Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.

BACKGROUND The pathogenesis of nonalcoholic steatohepatitis (NASH) is still unclear. Recently, the 2-hit hypothesis was proposed, in which nitric oxide production, representing oxidative stress, was proposed as a very important candidate for the second hit. METHODS The total study period was 10 weeks. A total of 20 rats were randomly divided into 2 groups. Group 1 was administered the Choline-Deficient, l-Amino Acid-Defined diet to produce a NASH model, and Group 2 as control received the Choline-Sufficient, l-Amino Acid-defined diet. The blood and tissue concentrations of nitrate + nitrite were measured using the Griess reagent and the expression levels of inducible nitric oxide synthase (iNOS) proteins and mRNA was determined by Western blotting. RESULTS In regard to nitric oxide (NO) and NO metabolites, there were significant differences in the blood (especially portal venous blood) as well as tissue (liver and visceral fat) concentrations between the 2 animal groups; the amounts of NO metabolites in the tissues were much higher in the NASH models. The level of nitrotyrosine was much markedly higher in the NASH models than in the controls. In regard to the tissue expression of iNOS a significant difference between the 2 groups was found in the visceral fat, especially in the mesenterium. CONCLUSIONS Based on these results, we hypothesize that the iNOS expression and NO levels in the visceral fat increase, with increased diffusion of NO and its metabolites into the liver, resulting in increased nitrotyrosine formation in the liver; this, in turn, induces inflammation, apoptosis, and fibrosis in the liver, which are one of the characteristic features of NASH.

[1]  W. Jiménez,et al.  Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. , 1996, Hepatology.

[2]  D. Pessayre,et al.  The ins and outs of mitochondrial dysfunction in NASH. , 2004, Diabetes & metabolism.

[3]  K. Tanaka,et al.  Inducible Nitric Oxide Synthase Deficiency Does Not Affect the Susceptibility of Mice to Atherosclerosis but Increases Collagen Content in Lesions , 2001, Circulation.

[4]  A. Marette,et al.  Mechanism of adipose tissue iNOS induction in endotoxemia. , 1999, The American journal of physiology.

[5]  Y. Okada,et al.  Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. , 2004, Biochemical and biophysical research communications.

[6]  R. Green,et al.  Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[7]  J. Tran van Nhieu,et al.  Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis , 2004, Hepatology.

[8]  J. Conklin,et al.  Generation of Nitric Oxide in the Opossum Lower Esophageal Sphincter during Physiological Experimentation , 2006, Yonsei medical journal.

[9]  A. García-Sánchez,et al.  Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. , 2002, Journal of hepatology.

[10]  D. Nakae.  Endogenous liver carcinogenesis in the rat * , 1999, Pathology international.

[11]  M. Radomski,et al.  Distribution of nitric oxide synthase in normal and cirrhotic human liver , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Ludwig,et al.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.

[13]  O. Bulbena,et al.  Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia , 1993, Hepatology.

[14]  M. Koruk,et al.  Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. , 2004, Annals of clinical and laboratory science.

[15]  M. Quer,et al.  Distant metastases in head and neck cancer patients who achieved loco‐regional control , 2000, Head & neck.

[16]  D. Pessayre,et al.  Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. , 2006, Mitochondrion.

[17]  A. Marette,et al.  Expression of Nitric Oxide Synthase in Skeletal Muscle: A Novel Role for Nitric Oxide as a Modulator of Insulin Action , 1997, Diabetes.

[18]  R. Groszmann,et al.  Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. , 1993, Gastroenterology.

[19]  Masao Tanaka,et al.  Inhibition of Inducible Nitric Oxide Synthase Prevents Hepatic, but Not Pulmonary, Injury Following Ischemia-Reperfusion of Rat Liver , 2006, Digestive Diseases and Sciences.

[20]  R. Austin,et al.  Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Sanyal,et al.  Insulin resistance in NASH. , 2005, Frontiers in bioscience : a journal and virtual library.

[22]  R. Schrier,et al.  Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: Evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis , 1995, Hepatology.

[23]  S. Kadakia,et al.  Nonalcoholic steatohepatitis: what we know in the new millennium , 2002, American Journal of Gastroenterology.

[24]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[25]  R. Schrier,et al.  Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. , 1996, The American journal of physiology.

[26]  A. Marette,et al.  Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. , 1997, The Biochemical journal.

[27]  W. Hon,et al.  Temporal expression of hepatic inducible nitric oxide synthase in liver cirrhosis. , 2005, World journal of gastroenterology.

[28]  C. Lieber,et al.  Acetaldehyde selectively stimulates collagen production in cultured rat liver fat‐storing cells but not in hepatocytes , 1990, Hepatology.

[29]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[30]  R. Unger,et al.  Fatty acid-induced β cell apoptosis: A link between obesity and diabetes , 1998 .

[31]  K. Okita,et al.  Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. , 2004, Biochemical and biophysical research communications.

[32]  A. Hart,et al.  Value of resection of pulmonary metastases in head and neck cancer patients , 1996, Head & neck.

[33]  H. Fukui,et al.  Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. , 2005, Alcoholism, clinical and experimental research.

[34]  M. Kogo,et al.  Induction chemotherapy is Associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity , 1998, Cancer.

[35]  J. Foidart,et al.  Enzyme-linked immunoassay (ELISA) for connective tissue components. , 1980, Analytical biochemistry.

[36]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.

[37]  K. Okita,et al.  The role of oxidative stress in NASH and fatty liver model. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[38]  J. Arenas,et al.  Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.